logo
Chardan Capital Reaffirms Their Buy Rating on Passage Bio (PASG)

Chardan Capital Reaffirms Their Buy Rating on Passage Bio (PASG)

In a report released yesterday, Geulah Livshits from Chardan Capital maintained a Buy rating on Passage Bio (PASG – Research Report), with a price target of $6.00. The company's shares closed yesterday at $0.27.
Confident Investing Starts Here:
Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Livshits is a 5-star analyst with an average return of 16.2% and a 37.68% success rate. Livshits covers the Healthcare sector, focusing on stocks such as Iovance Biotherapeutics, Solid Biosciences, and Passage Bio.
Passage Bio has an analyst consensus of Strong Buy, with a price target consensus of $7.33.
Based on Passage Bio's latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $15.41 million. In comparison, last year the company had a GAAP net loss of $16.71 million
Based on the recent corporate insider activity of 12 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PASG in relation to earlier this year. Last month, Orbimed Advisors Llc, a Major Shareholder at PASG sold 149,054.00 shares for a total of $49,704.12.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why LVMH Stock (MC) Is Catching Wall Street's Attention
Why LVMH Stock (MC) Is Catching Wall Street's Attention

Business Insider

time2 hours ago

  • Business Insider

Why LVMH Stock (MC) Is Catching Wall Street's Attention

French luxury products company LVMH Moët Hennessy Louis Vuitton, or LVMH (FR:MC) (LVMUY), is drawing strong support from Wall Street as several analysts maintain their Buy ratings. The recent wave of bullish ratings came despite the company reporting a challenging Q2 for 2025. Year-to-date, MC stock has declined more than 25%, reflecting broader market pressures on the luxury sector. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. LVMH is a European fashion house known for its iconic luxury brands like Louis Vuitton, Sephora, Fendi, Bulgari, and more. The company is primarily listed on the Euronext Paris exchange but also trades over-the-counter (OTC) in the U.S. LVMH Q2 2025 Results Overview In Q2, LVMH's core fashion and leather goods segment saw a sharp drop in sales, falling 9% year-over-year. The decline was larger than analyst expectations and marked the steepest drop among all of LVMH's business segments. This reflected continued weak demand for luxury products amid rising prices and economic uncertainty. Overall, LVMH's net profit dropped 22% year-over-year in the first half, while operating profit fell 15%. Looking ahead, the company warned that a full recovery will take time as it faces an industry-wide slowdown, with softer demand from Chinese shoppers and ongoing uncertainty among U.S. consumers. Wall Street Analysts Stay Bullish Despite the lackluster results, analysts have maintained their buy ratings on MC stock. Four-star-rated analyst Luca Solca at Bernstein reiterated his Buy rating on MC stock at a price target of €600, implying more than a 30% growth rate. Sola stated that the recent results showed effective cost control despite weak demand. He added that focus will now shift to how the company tackles its challenges and the potential impact on its business in the second half of the year. Likewise, RBC Capital's analyst Piral Dadhania maintained his Buy rating. He noted that while LVMH's recent underperformance presents a 'fairly attractive' risk/reward, it is supported by an expected near-term boost in Fashion & Leather Goods from easier comparisons. Is LVMH Stock a Good Buy? Overall, MC stock has received a Moderate Buy rating on TipRanks, backed by a total of 19 recommendations from analysts. It includes 10 Buys and nine Holds assigned in the last three months. The LVMH share price target is €565.14, which is 20% higher than the current trading level.

'Breakthrough EVs': Ford Stock (NYSE:F) Notches Up on New Battery Details
'Breakthrough EVs': Ford Stock (NYSE:F) Notches Up on New Battery Details

Business Insider

time4 hours ago

  • Business Insider

'Breakthrough EVs': Ford Stock (NYSE:F) Notches Up on New Battery Details

An electric vehicle (EV) is only as good as its battery, at the end of the day. Legacy automaker Ford (F) is likely aware of this, and has a novel new prospect coming as a result. The new line of EVs Ford has on tap will have an unexpected feature: a much smaller battery. But this is less a problem than you may think. In fact, Ford stock is up fractionally in Friday afternoon's trading. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. So how does a smaller battery win Ford's new EV line any friends? As it turns out, the smaller battery will produce a car with a similar range as those cars with bigger batteries. The battery in question will offer 51 kilowatt-hours of power, which is only about half the size of the batteries currently found in the F-150 Lightning. But if Ford can make an EV that gets the necessary 250-300 mile per charge range that most electric vehicles consider 'table stakes' these days, Ford might be able to make lighter-weight vehicles that are also less expensive, a combination that is only too important in a time when everyone is still feeling the inflationary pinch that started a few years ago and has yet to relent. 'Liquid Carbon' Mustang Of course, Ford is not all about electric vehicles; EVs represent a small portion of Ford's total sales, as gas engines still rule the day. And new reports about the Ford Mustang GTD 'Liquid Carbon' are already delivering some impressive visuals of the kind that might make Porsche (POAHY) quake in fear. Indeed, the GTD Liquid Carbon does look a lot like a 911 GT3 RS. Moreover, it is also a car that has bypassed the paint process and instead stuck with bonded carbon fiber all around. It is not all about looks, though, as reports note the GTD Liquid Carbon features a 'Performance' pack as a standard edition, complete with a DRS flap on the rear win, dive planes, and a 'bigger splitter,' all of which adds up to Ford living up to its promise of ' no boring cars.' Is Ford Stock a Good Buy Right Now? Turning to Wall Street, analysts have a Hold consensus rating on F stock based on two Buys, nine Holds and three Sells assigned in the past three months, as indicated by the graphic below. After a 8.85% rally in its share price over the past year, the average F price target of $10.74 per share implies 6.24% downside risk.

'An Equity Stake': Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money
'An Equity Stake': Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money

Business Insider

time5 hours ago

  • Business Insider

'An Equity Stake': Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money

Earlier this week, we got news that chip stock Intel (INTC) CEO Lip-Bu Tan would be meeting with the Trump cabinet in a bid to come up with some ideas to help get Intel back up and running to its fullest. Well, one of those ideas may have surfaced, and it is a doozy. New reports suggest that the United States government may buy a stake in Intel using CHIPS Act money. That news sent Intel shares blasting up, gaining over 4.5% in Friday afternoon's trading. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The reports noted that the CHIPS Act money—some of which Intel has already received—may be used to, if only in part, set up an equity stake in Intel. Naturally, this is still very early-stage stuff, and any part of it could change, including all of it. Intel already had access to billions in grants, and an additional $11 billion in loans connected to the CHIPS Act. And a lot of the CHIPS Act money is currently considered 'dormant,' reports note, with the Trump administration eager to get that funding into '…sectors it deems central to national security,' like chip processing. This will undoubtedly be welcome news for Intel, which has been laying off people and closing divisions for the last few months now. 'Essential' For National Security Meanwhile, word from D.A. Davidson analyst Gil Luria —who has a five-star rating on TipRanks—certainly approves of such a move. Luria noted that, while 'we don't want government to intervene and own private enterprise…this is national security.' Luria further noted, 'We can't rely on somebody else making shell casings for our nuclear arsenal. We have to get it right.' The idea is reasonable, even if the metaphor is a bit mixed. Still, this might be an interesting start to the notion of a 'sovereign wealth fund' that the Trump Administration advanced a while back. And it certainly will give Intel a leg up that needs to happen lest the United States lose ground in chip production altogether. Is Intel a Buy, Hold or Sell? Turning to Wall Street, analysts have a Hold consensus rating on INTC stock based on one Buy, 26 Holds and three Sells assigned in the past three months, as indicated by the graphic below. After a 14.33% rally in its share price over the past year, the average INTC price target of $22.24 per share implies 10.52% downside risk.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store